About this Event
Join our engaging and interactive event to learn about Via’s history of using long-acting buprenorphine and the impact that long-acting buprenorphine has on the outcomes and experiences of the people that we support.
Hear from experts at Via and our partners at Liverpool John Moore’s University (LJMU), who we worked collaboratively with on this research study, as well as the view from commissioners of drug and alcohol services and those people with lived experience.
Conference details
Location: Broadway House Conference Centre, Tothill Street, London, SW1H 9NQ
Date: Thursday 7 November 2024
Time: 10.30am
Conference agenda
10.00-10.30 Refreshments
10.30-10.40 Welcome and introductions
10.40-10.55 Exploring Via’s history of using long-acting buprenorphine
10.55-11.40 RESEARCH FINDINGS: what are the predictors of Via service user engagement with long-acting buprenorphine and do their outcomes differ to those prescribed oral OST? Presented by: Dr Yasir Abbasi (Executive Medical Director at Via), Professor Cathy Montgomery (Reader in Psychopharmacology at LJMU), and Devon De Silva (Innovation and Research Unit Manager at Via)
11.40-12.00 Tea break
12.00-12.30 PANEL SESSION: including people with lived experience, clinicians, commissioners and researchers.
12.30-1.00 Q&A and closing remarks
1.00-2.00 Lunch
2.00-2.30 End of event
Event Venue & Nearby Stays
Broadway House, Tothill Street, London, United Kingdom
GBP 0.00
